Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer.
McCaughan
Frank
F
Centre for Respiratory Research, Royal Free and University College Medical School, London, United Kingdom. frankmc@mrc-lmb.cam.ac.uk
Pole
Jessica C M
JC
Bankier
Alan T
AT
Konfortov
Bernard A
BA
Carroll
Bernadette
B
Falzon
Mary
M
Rabbitts
Terence H
TH
George
P Jeremy
PJ
Dear
Paul H
PH
Rabbitts
Pamela H
PH
D000368:Aged; D001984:Bronchial Neoplasms / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D002893:Chromosomes, Human, Pair 3 / Q000235:genetics*; D005260:Female; D005784:Gene Amplification / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009361:Neoplasm Invasiveness; D018307:Neoplasms, Squamous Cell / Q000235:genetics* / Q000503:physiopathology; D011230:Precancerous Conditions / Q000145:classification / Q000235:genetics* / Q000473:pathology; D055748:SOXB1 Transcription Factors / Q000235:genetics*
C527782:SOX2 protein, human; D055748:SOXB1 Transcription Factors